Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain

The COVID-19 pandemic represents a global health-crisis and a challenge at all societal, economic and health levels. With the first case having been reported in most of the European countries in January 2020 (1), it was not until March that the pandemic hit the territory and lead to an unprecedent hard lock-down in most countries.